Supernus, Britannia, US WorldMeds face amended US antitrust claims over drug for Parkinson’s disease
MLex Summary: Sage Chemical and TruPharma filed amended US antitrust claims accusing Supernus Pharmaceuticals, Britannia Pharmaceuticals, and US WorldMeds Partners of engaging in a conspiracy to restrain generic competition for branded...To view the full article, register now.
Already a subscriber? Click here to view full article